Glenna Auerback

465 total citations
8 papers, 252 citations indexed

About

Glenna Auerback is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Glenna Auerback has authored 8 papers receiving a total of 252 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Genetics and 3 papers in Oncology. Recurrent topics in Glenna Auerback's work include HER2/EGFR in Cancer Research (3 papers), Nicotinic Acetylcholine Receptors Study (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Glenna Auerback is often cited by papers focused on HER2/EGFR in Cancer Research (3 papers), Nicotinic Acetylcholine Receptors Study (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Glenna Auerback collaborates with scholars based in United States. Glenna Auerback's co-authors include Mark L. Rubinstein, Neal L. Benowitz, Anna‐Barbara Moscicki, Anna-Barbara Moscicki, Pamela N. Münster, Hendrikus G. J. Krouwer, Clifford A. Lowell, Soonmee Cha, Marc A. Shuman and James L. Rubenstein and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PEDIATRICS.

In The Last Decade

Glenna Auerback

8 papers receiving 249 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Glenna Auerback United States	5	104	77	71	70	66	8	252
Nam‐Hee Kim South Korea	11	85 0.8×	73 0.9×	35 0.5×	43 0.6×	9 0.1×	23	276
Neelima Radhakrishnan India	10	33 0.3×	27 0.4×	34 0.5×	47 0.7×	74 1.1×	35	302
MITHILESH KUMAR United States	11	47 0.5×	52 0.7×	19 0.3×	169 2.4×	17 0.3×	19	392
Mohammad Al-Haggar Egypt	11	30 0.3×	87 1.1×	37 0.5×	8 0.1×	25 0.4×	47	330
Emanuela Susani Italy	9	64 0.6×	35 0.5×	18 0.3×	93 1.3×	65 1.0×	17	403
R. Insa Spain	8	51 0.5×	203 2.6×	15 0.2×	26 0.4×	20 0.3×	18	360
Natalia Mejía Colombia	10	30 0.3×	118 1.5×	35 0.5×	13 0.2×	10 0.2×	21	304
Deepa Bhattarai United States	9	31 0.3×	111 1.4×	11 0.2×	55 0.8×	68 1.0×	12	320
İlyas Okur Türkiye	12	136 1.3×	124 1.6×	32 0.5×	11 0.2×	12 0.2×	62	372
Markus Ponleitner Austria	8	35 0.3×	51 0.7×	96 1.4×	65 0.9×	4 0.1×	34	230

Countries citing papers authored by Glenna Auerback

Since Specialization

Citations

This map shows the geographic impact of Glenna Auerback's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glenna Auerback with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glenna Auerback more than expected).

Fields of papers citing papers by Glenna Auerback

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glenna Auerback. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glenna Auerback. The network helps show where Glenna Auerback may publish in the future.

Co-authorship network of co-authors of Glenna Auerback

This figure shows the co-authorship network connecting the top 25 collaborators of Glenna Auerback. A scholar is included among the top collaborators of Glenna Auerback based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glenna Auerback. Glenna Auerback is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Chien, A. Jo, Pamela N. Münster, Michelle Melisko, et al.. (2014). Phase I Dose-Escalation Study of 5-Day Intermittent Oral Lapatinib Therapy in Patients With Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer. Journal of Clinical Oncology. 32(14). 1472–1479. 30 indexed citations

Rubenstein, James L., Jing Li, Lingjing Chen, et al.. (2012). Multicenter phase 1 trial of intraventricular immunochemotherapy in recurrent CNS lymphoma. Blood. 121(5). 745–751. 93 indexed citations

Chien, A. Jo, K. M. Koch, Glenna Auerback, et al.. (2011). A phase I dose and exposure escalation study of 5-day intermittent oral lapatinib (Lp) therapy in patients with HER2-overexpressing breast cancer (BC).. Journal of Clinical Oncology. 29(15_suppl). e11077–e11077. 2 indexed citations

Rubinstein, Mark L., Neal L. Benowitz, Glenna Auerback, & Anna‐Barbara Moscicki. (2009). Withdrawal in adolescent light smokers following 24-hour abstinence. Nicotine & Tobacco Research. 11(2). 185–189. 31 indexed citations

Chien, A. Jo, Glenna Auerback, Hope S. Rugo, et al.. (2009). A phase I dose-escalation study of 5-day intermittent oral lapatinib therapy with biomarker analysis in patients with HER-2–overexpressing breast cancer. Journal of Clinical Oncology. 27(15_suppl). e14530–e14530. 4 indexed citations

Rubinstein, Mark L., Neal L. Benowitz, Glenna Auerback, & Anna-Barbara Moscicki. (2008). Rate of Nicotine Metabolism and Withdrawal Symptoms in Adolescent Light Smokers. PEDIATRICS. 122(3). e643–e647. 54 indexed citations

Rubinstein, Mark L., Neal L. Benowitz, Glenna Auerback, & Anna Barbara Moscicki. (2008). 69: Withdrawal in Adolescent Light Smokers Following 24 Hours of Abstinence. Journal of Adolescent Health. 42(2). 46–46. 1 indexed citations

Rubinstein, Mark L., Neal L. Benowitz, Glenna Auerback, & Anna‐Barbara Moscicki. (2008). A Randomized Trial of Nicotine Nasal Spray in Adolescent Smokers. PEDIATRICS. 122(3). e595–e600. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact